Re: Clinical Outcomes in Octogenarians Treated with Docetaxel as First-Line Chemotherapy for Castration-Resistant Prostate Cancer

被引：0
|
作者：
Griebling, Tomas L.
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 01期
关键词：
D O I：
10.1016/j.juro.2016.10.035
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [31] Impact of body composition parameters on clinical outcomes in patients with metastatic castration-resistant prostate cancer treated with docetaxel
    Power, Derek Gerard
    Cushen, Samantha
    McDermott, Ray
    Lim, Marvin Chang Jui
    Mceneaney, Peter
    Daly, Louise
    Griffin, Brendan
    Murphy, Kevin P.
    Ryan, Aoife M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer
    Xu, Nanwei
    Zhao, Jinge
    Zhao, Fengnian
    Liu, Haoyang
    Yin, Wenlian
    Zhu, Sha
    Nie, Ling
    Sun, Guangxi
    Zheng, Linmao
    Liu, Zhenhua
    Cai, Diming
    Chen, Junru
    Dai, Jindong
    Ni, Yuchao
    Wang, Zhipeng
    Zhang, Xingming
    Liang, Jiayu
    Chen, Yuntian
    Hu, Xu
    Pan, Xiuyi
    Yin, Xiaoxue
    Zhu, Xudong
    Zhang, Yaowen
    Wang, Zilin
    Zeng, Yuhao
    Wang, Minghao
    Shen, Pengfei
    Chen, Ni
    Zeng, Hao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7247 - 7258
  • [33] Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer
    Nanwei Xu
    Jinge Zhao
    Fengnian Zhao
    Haoyang Liu
    Wenlian Yin
    Sha Zhu
    Ling Nie
    Guangxi Sun
    Linmao Zheng
    Zhenhua Liu
    Diming Cai
    Junru Chen
    Jindong Dai
    Yuchao Ni
    Zhipeng Wang
    Xingming Zhang
    Jiayu Liang
    Yuntian Chen
    Xu Hu
    Xiuyi Pan
    Xiaoxue Yin
    Xudong Zhu
    Yaowen Zhang
    Zilin Wang
    Yuhao Zeng
    Minghao Wang
    Pengfei Shen
    Ni Chen
    Hao Zeng
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7247 - 7258
  • [34] Results of a phase II study of picoplatin with docetaxel and prednisone in first-line treatment of castration-resistant prostate cancer (CRPC)
    De Jager, R. L.
    Roman, L.
    Lopatkin, N.
    Karlov, P.
    Breitz, H.
    Earhart, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [35] Prognostic impact of pre-treatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel
    Buttigliero, C.
    Tucci, M.
    Vignani, F.
    Pisano, C.
    Bertaglia, V.
    Pignataro, D.
    Bironzo, P.
    Guglielmini, P. F.
    Scagliotti, G. V.
    Di Maio, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Is chemical/surgical castration necessary during docetaxel chemotherapy for castration-resistant prostate cancer?
    Watanabe, Masahito
    Kanao, Kent
    Muramatsu, Hiroyuki
    Morinaga, Shingo
    Kajikawa, Keishi
    Kobayashi, Ikuo
    Nishikawa, Genya
    Kato, Yoshiharu
    Nakamura, Kogenta
    Sumitomo, Makoto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] Overall survival of men with metastatic castration-resistant prostate cancer (mCRPC) receiving first-line docetaxel-containing chemotherapy according to their participation (or not) in clinical trials.
    Goyal, Jatinder
    Huang, Peng
    Tyagi, Prachi
    Oh, Daniel
    Carducci, Michael Anthony
    Eisenberger, Mario A.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [38] Re: First-Line Treatment in Senior Adults with Metastatic Castration-Resistant Prostate Cancer: A Prospective International Registry
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2017, 197 (01): : 157 - 157
  • [39] Carboplatin plus weekly docetaxel as second-line chemotherapy in docetaxel-resistant and castration-resistant prostate cancer (CRPC).
    Reuter, C. W.
    Gruenwald, V.
    Ivanyi, P.
    Morgan, M. A.
    Fenner, M.
    Ganser, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Prostate-specific antigen testing in men with metastatic castration-resistant prostate cancer treated with docetaxel chemotherapy
    Tsai, Yuh-Shyan
    Tzai, Tzong-Shin
    UROLOGICAL SCIENCE, 2015, 26 (04) : 277 - 277
12345